-
2
-
-
15244355862
-
A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China
-
Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607-12.
-
(2005)
Br J Cancer
, vol.92
, pp. 607-612
-
-
Shi, J.1
Zhu, L.2
Liu, S.3
Xie, W.F.4
-
3
-
-
0035061788
-
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach
-
Camma C, Giunta M, Andreone P, Craxi A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001;34:593-602.
-
(2001)
J Hepatol
, vol.34
, pp. 593-602
-
-
Camma, C.1
Giunta, M.2
Andreone, P.3
Craxi, A.4
-
4
-
-
61449187479
-
Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: A meta-analysis
-
Yang YF, Zhao W, Zhong YD, Xia HM, Shen L, Zhang N. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat 2009;16:265-71.
-
(2009)
J Viral Hepat
, vol.16
, pp. 265-271
-
-
Yang, Y.F.1
Zhao, W.2
Zhong, Y.D.3
Xia, H.M.4
Shen, L.5
Zhang, N.6
-
5
-
-
5844370499
-
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
-
Hepatoma Prevention Study Group
-
Muto Y, Moriwaki H, Ninomiya M, et al., Hepatoma Prevention Study Group. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-7.
-
(1996)
N Engl J Med
, vol.334
, pp. 1561-1567
-
-
Muto, Y.1
Moriwaki, H.2
Ninomiya, M.3
-
6
-
-
33845760039
-
Prevention of hepatocellular carcinoma recurrence with α-interferon after liver resection in HCV cirrhosis
-
Mazzaferro V, Romito R, Schiavo M, et al. Prevention of hepatocellular carcinoma recurrence with α-interferon after liver resection in HCV cirrhosis. Hepatology 2006;44:1543-54.
-
(2006)
Hepatology
, vol.44
, pp. 1543-1554
-
-
Mazzaferro, V.1
Romito, R.2
Schiavo, M.3
-
7
-
-
19944432263
-
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
-
Schiffer E, Housset C, Cacheux W, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005;41:307-14.
-
(2005)
Hepatology
, vol.41
, pp. 307-314
-
-
Schiffer, E.1
Housset, C.2
Cacheux, W.3
-
8
-
-
51249111742
-
C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice
-
Knight B, Tirnitz-Parker JE, Olynyk JK. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice. Gastroenterology 2008;135:969-79.
-
(2008)
Gastroenterology
, vol.135
, pp. 969-979
-
-
Knight, B.1
Tirnitz-Parker, J.E.2
Olynyk, J.K.3
-
9
-
-
0038757830
-
Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis
-
Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003;34:292-6.
-
(2003)
Nat Genet
, vol.34
, pp. 292-296
-
-
Parviz, F.1
Matullo, C.2
Garrison, W.D.3
-
10
-
-
33744795211
-
Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver
-
Battle MA, Konopka G, Parviz F, et al. Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A 2006;103:8419-24.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 8419-8424
-
-
Battle, M.A.1
Konopka, G.2
Parviz, F.3
-
11
-
-
33645215441
-
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer
-
Tanaka T, Jiang S, Hotta H, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer. J Pathol 2006;208:662-72.
-
(2006)
J Pathol
, vol.208
, pp. 662-672
-
-
Tanaka, T.1
Jiang, S.2
Hotta, H.3
-
12
-
-
44649161207
-
Tissue-specific transcription factors in progression of epithelial tumors
-
(Mosc)
-
Lazarevich NL, Fleishman DI. Tissue-specific transcription factors in progression of epithelial tumors. Biochemistry (Mosc) 2008;73:573-91.
-
(2008)
Biochemistry
, vol.73
, pp. 573-591
-
-
Lazarevich, N.L.1
Fleishman, D.I.2
-
13
-
-
56149088742
-
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene
-
Yin C, Lin Y, Zhang X, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene. Hepatology 2008;48:1528-39.
-
(2008)
Hepatology
, vol.48
, pp. 1528-1539
-
-
Yin, C.1
Lin, Y.2
Zhang, X.3
-
14
-
-
77149123633
-
Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats
-
Yue HY, Yin C, Hou JL, et al. Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats. Gut 2010;59:236-46.
-
(2010)
Gut
, vol.59
, pp. 236-246
-
-
Yue, H.Y.1
Yin, C.2
Hou, J.L.3
-
16
-
-
34249980343
-
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
-
Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-56.
-
(2007)
Gastroenterology
, vol.132
, pp. 2542-2556
-
-
Ma, S.1
Chan, K.W.2
Hu, L.3
-
17
-
-
33847686753
-
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
-
Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007;120:1444-50.
-
(2007)
Int J Cancer
, vol.120
, pp. 1444-1450
-
-
Yin, S.1
Li, J.2
Hu, C.3
-
19
-
-
40449099255
-
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
-
Yamashita T, Forgues M, Wang W, et al. EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 2008;68:1451-61.
-
(2008)
Cancer Res
, vol.68
, pp. 1451-1461
-
-
Yamashita, T.1
Forgues, M.2
Wang, W.3
-
20
-
-
49249122615
-
Wnt/β-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells
-
Yang W, Yan HX, Chen L, et al. Wnt/β-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 2008;68:4287-95.
-
(2008)
Cancer Res
, vol.68
, pp. 4287-4295
-
-
Yang, W.1
Yan, H.X.2
Chen, L.3
-
21
-
-
0028914210
-
Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver
-
Flodby P, Liao DZ, Blanck A, Xanthopoulos KG, Hallstrom IP. Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinog 1995;12:103-9.
-
(1995)
Mol Carcinog
, vol.12
, pp. 103-109
-
-
Flodby, P.1
Liao, D.Z.2
Blanck, A.3
Xanthopoulos, K.G.4
Hallstrom, I.P.5
-
22
-
-
0029915773
-
Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours
-
Kalkuhl A, Kaestner K, Buchmann A, Schwarz M. Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. Carcinogenesis 1996;17:609-12.
-
(1996)
Carcinogenesis
, vol.17
, pp. 609-612
-
-
Kalkuhl, A.1
Kaestner, K.2
Buchmann, A.3
Schwarz, M.4
-
23
-
-
0035300430
-
Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma
-
Xu L, Hui L, Wang S, et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001;61:3176-81.
-
(2001)
Cancer Res
, vol.61
, pp. 3176-3181
-
-
Xu, L.1
Hui, L.2
Wang, S.3
-
24
-
-
9644254191
-
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
-
Lee JS, Chu IS, Mikaelyan A, et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004;36:1306-11.
-
(2004)
Nat Genet
, vol.36
, pp. 1306-1311
-
-
Lee, J.S.1
Chu, I.S.2
Mikaelyan, A.3
-
25
-
-
34548145815
-
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition
-
Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-47.
-
(2007)
J Biol Chem
, vol.282
, pp. 23337-23347
-
-
Zeisberg, M.1
Yang, C.2
Martino, M.3
-
26
-
-
33645302628
-
The epithelial-mesenchymal transition: New insights in signaling, development, and disease
-
Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-81.
-
(2006)
J Cell Biol
, vol.172
, pp. 973-981
-
-
Lee, J.M.1
Dedhar, S.2
Kalluri, R.3
Thompson, E.W.4
-
27
-
-
33846819015
-
Transcriptional regulation of epithelial-mesenchymal transition
-
Teng Y, Zeisberg M, Kalluri R. Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest 2007;117:304-6.
-
(2007)
J Clin Invest
, vol.117
, pp. 304-306
-
-
Teng, Y.1
Zeisberg, M.2
Kalluri, R.3
-
29
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
-
30
-
-
33847419142
-
Molecular definition of breast tumor heterogeneity
-
Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007;11:259-73.
-
(2007)
Cancer Cell
, vol.11
, pp. 259-273
-
-
Shipitsin, M.1
Campbell, L.L.2
Argani, P.3
-
31
-
-
5444256238
-
Self-renewal and solid tumor stem cells
-
Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004;23:7274-82.
-
(2004)
Oncogene
, vol.23
, pp. 7274-7282
-
-
Al-Hajj, M.1
Clarke, M.F.2
-
32
-
-
0033895709
-
Wnt signaling and cancer
-
Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
-
(2000)
Genes Dev
, vol.14
, pp. 1837-1851
-
-
Polakis, P.1
-
33
-
-
34248674146
-
WNT/β-catenin signaling in liver health and disease
-
Thompson MD, Monga SP. WNT/β-catenin signaling in liver health and disease. Hepatology 2007;45:1298-305.
-
(2007)
Hepatology
, vol.45
, pp. 1298-1305
-
-
Thompson, M.D.1
Monga, S.P.2
-
34
-
-
0345599013
-
Autoregulation of E-cadherin expression by cadherincadherin interactions: The roles of β-catenin signaling, Slug, and MAPK
-
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherincadherin interactions: the roles of β-catenin signaling, Slug, and MAPK. J Cell Biol 2003;163:847-57.
-
(2003)
J Cell Biol
, vol.163
, pp. 847-857
-
-
Conacci-Sorrell, M.1
Simcha, I.2
Ben-Yedidia, T.3
Blechman, J.4
Savagner, P.5
Ben-ZE'ev, A.6
-
35
-
-
44449111555
-
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
-
Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008;68:3645-54.
-
(2008)
Cancer Res
, vol.68
, pp. 3645-3654
-
-
Onder, T.T.1
Gupta, P.B.2
Mani, S.A.3
Yang, J.4
Lander, E.S.5
Weinberg, R.A.6
-
36
-
-
36348991571
-
Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma
-
Yamashita T, Budhu A, Forgues M, Wang XW. Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma. Cancer Res 2007;67:10831-9.
-
(2007)
Cancer Res
, vol.67
, pp. 10831-10839
-
-
Yamashita, T.1
Budhu, A.2
Forgues, M.3
Wang, X.W.4
|